Fulcrum Health Partners advises urgent care organizations across payer strategy, managed care contracting, reimbursement analytics, payer enrollment, contract implementation, underpayment recovery, market expansion, and transaction advisory — from a single market to a national multi-state platform.
Two centers in the same brand, forty miles apart, can be paid on different methodologies, under different entities, at rates set years apart — for the same visit.
Urgent care reimbursement is unusually sensitive to structure. A visit may be paid as a global case rate under S9083, as fee-for-service against a percentage of Medicare, or under a hybrid that switches on service intensity. Which one applies depends on the payer, the product, the contracting entity, the Tax ID, and the market — not on the care delivered.
Scale compounds it. Acquisitions bring legacy agreements that were negotiated for a smaller footprint and never revisited. De novos get loaded onto whichever contract was easiest to amend. Evergreen terms roll forward without escalators. Enrollment lags a location's opening by months. And because each individual variance is small, none of them triggers a review — until they are multiplied across hundreds of thousands of encounters.
A few dollars per visit is a rounding error on one claim and a material EBITDA line across a platform.
Illustrative S9083 case rate dispersion across one platform's largest commercial payer
Illustrative only. Figures are fabricated for demonstration and are not Fulcrum client data or Fulcrum proprietary benchmark data.
Retail storefronts. Hybrid urgent care and occupational medicine. Health-system-affiliated centers. De novo sites opening into markets where you have no contracts yet.
Each of those carries its own contracting entity, product participation, and rate structure — and each one arrives on the platform through a different door.
Eight capabilities that cover the full distance between a payer's rate sheet and the cash that reaches your account.
Negotiate commercial, Medicare Advantage, and managed Medicaid agreements across the portfolio. We evaluate payer positioning, build renewal and escalation strategy, model every proposal before it is sent, and run the negotiation.
Reimbursement analyzed by payer, market, CPT/HCPCS code, product, location, Tax ID, and methodology — then benchmarked, so the largest dollars are addressed first rather than the loudest complaints.
One master abstract for the platform: agreements, fee schedules, amendments, effective and renewal dates, termination provisions, escalators, methodologies, and the terms that decide what a visit is worth.
Participation established and maintained as the footprint grows — new Tax IDs, acquired entities, de novo sites, and new states. Fulcrum handles the strategic side of enrollment and works alongside your credentialing function.
A negotiated rate is a promise until it is loaded correctly on both sides. We translate signed economics into payment logic, validate the payer's configuration, and confirm the first claims pay the way the contract says they should.
Every paid claim compared against the contractual methodology that governs it. Leakage is identified at the code and payer level, quantified, and pursued to resolution — with the pattern documented so it does not recur.
Support when reimbursement is contested: payment policy changes, downcoding and edit disputes, retrospective recoupments, network actions, and escalation with the plan when the routine channels have stopped working.
Payer contracts and reimbursement read before the model is signed. Below-market agreements surfaced, post-close opportunity priced, and a reimbursement value-creation roadmap handed to whoever owns the asset on day one.
A platform can look uniform on the org chart and be entirely fragmented underneath it. This is what a master contract abstract looks like when the same brand's agreements are lined up side by side.
Contract Inventory — Master Abstract · Multi-state urgent care platform · 18 agreements · illustrative sample (fabricated entities and rates; payer names representative; markets withheld). Scroll the table to read the full portfolio.
| Ref | Entity | Payer (Parent) | Plan / Product | Line of Business | Market | Eff. | Renewal | Method | Rate basis / S9083 | Escalator | Market position | Priority | Key flags |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UC-001 | Entity A | Blue Cross Blue Shield | Blue Choice PPO | Commercial | Market A | 2024 | 3-yr, then 1-yr auto | Case Rate | S9083 $164 | CPI-U (cap 3%) | Above market | Low | Recently renegotiated; protect at renewal |
| UC-002 | Entity B | Blue Cross Blue Shield | BlueCare PPO | Commercial | Market B | 2019 | Evergreen (1-yr auto) | Case Rate | S9083 $113 | None | Below market | High | Legacy acquired entity; six years without a rate action |
| UC-003 | Entity A | UnitedHealthcare | Choice Plus | Commercial | Market A | 2022 | Evergreen (1-yr auto) | FFS | 128% CMS NPFS | None | At market | Medium | All-products clause; unilateral amendment right |
| UC-004 | Entity B | UnitedHealthcare | Navigate HMO | Commercial | Market D | 2018 | Evergreen (1-yr auto) | Case Rate | S9083 $96 | None | Below market | High | Lowest case rate in portfolio; no escalator; 90-day term |
| UC-005 | Entity A | Aetna | Open Choice PPO | Commercial | Market C | 2023 | 2-yr term | Case Rate | S9083 $124 | Fixed 2.0% | At market | Medium | Escalator present but below regional trend |
| UC-006 | Entity C | Aetna | Medicare Advantage HMO | Medicare Advantage | Market A | 2021 | Evergreen (1-yr auto) | FFS | 100% CMS NPFS | Follows CMS | Below market | High | Floor at Medicare; no commercial uplift on MA volume |
| UC-007 | Entity A | Cigna | Open Access Plus | Commercial | Market A | 2023 | 3-yr, then 1-yr auto | Hybrid | S9083 $131 / FFS carve-out | CPI-U (cap 2.5%) | At market | Low | Hybrid logic requires configuration testing each year |
| UC-008 | Entity B | Cigna | LocalPlus | Commercial | Market B | 2020 | Evergreen (1-yr auto) | FFS | 112% CMS NPFS | None | Below market | High | Below platform average; same payer paying Entity A more |
| UC-009 | Entity C | Humana | Medicare Advantage PPO | Medicare Advantage | Market C | 2022 | Evergreen (1-yr auto) | FFS | 105% CMS NPFS | Follows CMS | At market | Monitor | Growing MA share; revisit at next benchmark cycle |
| UC-010 | Entity A | Superior HealthPlan (Centene) | STAR Managed Medicaid | Medicaid MCO | Market A | 2021 | State contract cycle | Case Rate | S9083 $78 | State-directed | At market | Monitor | Rate is state-directed; volume mix is the lever, not price |
| UC-011 | Entity B | Molina Healthcare | Managed Medicaid | Medicaid MCO | Market D | 2019 | Evergreen (1-yr auto) | Case Rate | S9083 $71 | None | Below market | Medium | Below other Medicaid MCOs in the same state |
| UC-012 | Entity A | Ambetter (Centene) | Exchange Silver/Bronze | Marketplace | Market A | 2023 | 1-yr, auto-renew | Case Rate | S9083 $102 | None | Below market | Medium | Marketplace volume rising; rate set at commercial minus |
| UC-013 | Entity C | Oscar Health | Exchange EPO | Marketplace | Market C | 2024 | 1-yr, auto-renew | FFS | 118% CMS NPFS | None | At market | Low | New participation; validate configuration after first quarter |
| UC-014 | Entity B | Multiplan | Rental network access | Network / Rental | Multi | 2017 | Evergreen | FFS | Discount off billed | None | Below market | High | Silent-PPO leakage risk; steerage without volume commitment |
| UC-015 | Entity A | First Health (Aetna) | Rental network access | Network / Rental | Multi | 2018 | Evergreen | FFS | Discount off billed | None | Below market | Medium | Overlaps direct commercial agreements in two markets |
| UC-016 | Entity C | State Fund | Workers' compensation | Workers' Comp | Market C | 2020 | Fee-schedule driven | FFS | State WC fee schedule | State-set | At market | Monitor | Occ-med volume growing; confirm site eligibility by location |
| UC-017 | Entity A | Regional Health Plan | Commercial PPO | Commercial | Market C | 2022 | 3-yr term | Case Rate | S9083 $141 | Fixed 3.0% | Above market | Low | Strongest agreement in portfolio; use as negotiation comp |
| UC-018 | Entity B | Regional Health Plan | Commercial PPO | Commercial | Market B | 2018 | Evergreen (1-yr auto) | Case Rate | S9083 $109 | None | Below market | High | Same payer, same state, $32 apart from UC-017 |
S9083 = HCPCS global per-visit case rate for urgent care. "Below / At / Above market" compares the case rate or % of Medicare basis to an illustrative regional benchmark (placeholder values, not Fulcrum proprietary data) using a ±5% band. Sort any column; filter by line of business, methodology, or priority. Every value on this page is fabricated for demonstration.
The point is not any single row. It is that rows UC-017 and UC-018 are the same payer, in the same state, thirty-two dollars apart — and nothing in the operating model would ever surface that.
Operations consolidate quickly. Reimbursement does not. Every acquisition, every new Tax ID, and every market entry adds another set of agreements to a portfolio that was never designed as one.
Fulcrum builds and maintains that chain — so a rate change made at the contracting table can be traced all the way to the remittance, and a payment variance can be traced all the way back to the clause that caused it.
Illustrative structure. Entity counts, agreement counts and flags are fabricated to show the shape of the problem, not any client's portfolio.
It becomes revenue only if the organization is enrolled correctly, the agreement is configured correctly, the claims pay correctly, and someone is watching. Fulcrum works the whole distance.
Every agreement abstracted and every rate positioned against the market by payer, product, methodology, code and geography.
Opportunity priced and sequenced. Volume-weighted gap decides the order of operations, not the renewal calendar alone.
Proposals modeled before they are sent. Fulcrum runs the negotiation, or sits beside your team through it, including escalation and termination scenarios.
Participation established for the entities, Tax IDs and locations the agreement is meant to cover — before go-live, not after the first denial.
Negotiated economics translated into payment logic on both sides, and the payer's load verified rather than assumed.
First claims tested against the contract. Case-rate and fee-for-service logic checked separately, because hybrids fail quietly.
Variance quantified, root cause identified, and underpayments pursued to resolution with the pattern documented so it does not repeat.
Performance monitored across the portfolio, renewals worked on a calendar, and the next cycle's targets set from live data.
Urgent care is an acquisition-driven business. In most deals, volume and site economics are underwritten carefully and the payer contracts are read for legal risk only — which is where the value, and the exposure, actually sits.
A platform trading on encounter volume is really trading on the contracts behind those encounters.
Fulcrum reads payer agreements as economic instruments: which are below market and by how much, which carry evergreen terms with no escalator, where concentration creates exposure, and what a realistic post-close rate action is worth in the first eighteen months.
The output is a quantified reimbursement value-creation roadmap — the version of the diligence memo that survives contact with the operating plan.
Growth adds contracts faster than it adds contracting capacity. Fulcrum keeps the payer side ahead of the footprint.
Reimbursement is the line item most often assumed and least often tested. We test it — before the bid and before the process.
Payer contracts and reimbursement opened before the model is signed — the risk conventional diligence leaves closed, and the opportunity it never prices.
Explore capability → Analyze & TransactBuy-side and sell-side reimbursement diligence, Quality of Reimbursement, and value-creation strategy across the full deal lifecycle.
Explore capability → CapitalReimbursement diligence and value creation across the hold — from thesis through the 100-day plan to exit.
Explore industry →Trusted by leading healthcare organizations nationwide
Reimbursement is not one of several practice areas here. It is the firm.
Decades of experience from both sides of the payer–provider relationship, across commercial, Medicare Advantage, Medicaid and exchange lines of business.
Experience across all 50 states and every major payer category — the range a multi-state urgent care platform needs from a single advisor.
Contract and claims data turned into reimbursement intelligence — rate position, opportunity, and payment variance at the code and payer level.
Connections spanning 25,000+ payer contacts open doors and move negotiations faster than going it alone.
12,000+ agreements negotiated at a 99% success rate. We do not stop at recommendations — we run the negotiation, the implementation, and the escalation.
Fulcrum is not a generalist consulting firm. Healthcare reimbursement is the center of the work, not an adjacent service line.
By comparing them to what the same payers pay comparable urgent care providers in the same markets — not to a national average. Fulcrum benchmarks S9083 case rates and fee-for-service schedules by payer, product, market and contracting entity, then weights each gap by your actual volume so the answer is expressed in dollars rather than percentiles.
Neither is inherently better. A global case rate is favorable when your average visit intensity sits below what the rate assumes, and unfavorable when a meaningful share of visits include procedures, imaging, labs or injections that fee-for-service would pay separately. The right question is not which methodology to prefer but which one fits your actual encounter mix in that market — and whether the contract's carve-outs and exclusions match how you actually deliver care. We model both against your claims before recommending a position.
Yes. Cross-market benchmarking is usually the first engagement, because it is what makes prioritization possible. Reimbursement is analyzed by payer, product, market, Tax ID, location and methodology, which is typically the first time a platform sees the same payer's rates for its own entities side by side.
By volume-weighted opportunity, adjusted for leverage and timing. A twelve percent gap on a low-volume product is worth less than a four percent gap on your largest commercial payer. We price each gap, overlay renewal and termination windows, assess where you actually have leverage, and produce a sequenced calendar rather than a list.
Yes — for de novo sites, acquired locations, new Tax IDs and new state entries. Fulcrum handles the strategic side of payer enrollment and participation and works alongside your credentialing function or vendor; we do not perform credentialing or primary source verification. Because payer review commonly runs 60 to 180 days, enrollment planning should start well before a location opens.
By validating paid claims against the contractual methodology that governs each one — case rate, fee schedule, or hybrid logic — rather than against an expected-payment average. That comparison surfaces the variance, the code and payer pattern behind it, and whether the cause is a payer configuration error, a contract misload on your side, or a payment policy applied outside the agreement.
Yes. Black Box Diligence is built for exactly this: contracts abstracted at diligence speed, rates benchmarked against the market, concentration and termination exposure flagged, and post-close rate opportunity quantified so it can be underwritten rather than assumed.
Deliberately, and rarely all at once. Some legacy agreements are worth keeping — an acquired entity occasionally holds the best rate in the portfolio. The work is to inventory what exists, identify which agreements should be migrated to the platform entity and which should be preserved, sequence the migrations around termination and notice provisions, and make sure enrollment and payment configuration follow each move.
Yes. Engagements range from advisory support behind your internal contracting team to Fulcrum leading the negotiation directly with the plan, including escalation and termination scenarios. Most multi-site platforms use a mix: Fulcrum leads the largest payers and supports the rest.
Whether you operate five urgent care centers or a national multi-state platform, Fulcrum helps you understand your payer economics, identify the opportunities, execute the negotiations, and build the infrastructure required to capture the value.
